Statistics for Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
Total visits
| views | |
|---|---|
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | 2 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:f6fe6d33-11e3-45c5-9888-402da8e5739a | 22 |
| java.util.UUID:1558e8df-28a6-4001-a5b7-efa7080c4c21 | 11 |
| java.util.UUID:0ef6c6a0-fc1f-407e-bd4d-1459e852ca3c | 8 |
| Ravandi2021Management-CCBY.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Bloomington | 2 |